Aquinox Pharma (AQXP) Misses Q2 EPS by 8c

Aquinox Pharma (NASDAQ: AQXP) reported Q2 EPS of ($0.59), $0.08 worse than the analyst estimate of ($0.51). Revenue for the quarter came in at $229 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Aquinox Pharma (AQXP) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance